149 related articles for article (PubMed ID: 19998502)
21. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
[TBL] [Abstract][Full Text] [Related]
22. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
[TBL] [Abstract][Full Text] [Related]
23. Urocanic acid-modified chitosan-mediated p53 gene delivery inducing apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its antitumor effect in vitro and in vivo.
Wang W; Yao J; Zhou JP; Lu Y; Wang Y; Tao L; Li YP
Biochem Biophys Res Commun; 2008 Dec; 377(2):567-572. PubMed ID: 18929532
[TBL] [Abstract][Full Text] [Related]
24. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
25. Targeting and eradicating hepatic cancer cells with a cancer-specific vector carrying the Buforin II gene.
Wang Y; Qu L; Gong L; Sun L; Gong R; Si J
Cancer Biother Radiopharm; 2013 Oct; 28(8):623-30. PubMed ID: 24041444
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
Sun J; Wang B; Liu Y; Zhang L; Ma A; Yang Z; Ji Y; Liu Y
Cancer Lett; 2014 Dec; 355(1):25-33. PubMed ID: 25242357
[TBL] [Abstract][Full Text] [Related]
27. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
[TBL] [Abstract][Full Text] [Related]
28. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
29. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
30. Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways.
Qian YY; Li WY; Yan Y; Zhao XY; Yang T; Fang CC; Hou JJ; Liu YQ
Chin J Integr Med; 2019 Nov; 25(11):845-852. PubMed ID: 31127506
[TBL] [Abstract][Full Text] [Related]
31. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
[TBL] [Abstract][Full Text] [Related]
32. [Nanoparticle-mediated endostatin gene therapy targeting hepatocellular carcinoma utilizing heat-inducible promoter].
Zhou JJ; Chen RF; Li ZH; Zhou QB; Tang QB; He XY; Lu HW; Guo N
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):795-9. PubMed ID: 19595115
[TBL] [Abstract][Full Text] [Related]
33. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
34. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.
Do TN; Rosal RV; Drew L; Raffo AJ; Michl J; Pincus MR; Friedman FK; Petrylak DP; Cassai N; Szmulewicz J; Sidhu G; Fine RL; Brandt-Rauf PW
Oncogene; 2003 Mar; 22(10):1431-44. PubMed ID: 12629507
[TBL] [Abstract][Full Text] [Related]
35. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of lentivirus transduced anti-telomerase siRNA therapy on hepatocellular carcinoma in nude mice].
Zhang Y; Gao Y; Xi LS; Deng L; Yin AH; Wang XH; Sun BC
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):410-3. PubMed ID: 19950547
[TBL] [Abstract][Full Text] [Related]
37. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
38. [Hepatitis B virus X protein suppresses adriamycin-induced apoptosis of hepatocellular carcinoma cells and expression of p53 and PTEN].
Wang X; Yang L; She JJ; Fan HM; Zhang FC; Chen YM; Xie QF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1775-8. PubMed ID: 20813662
[TBL] [Abstract][Full Text] [Related]
39. Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.
Koom WS; Park SY; Kim W; Kim M; Kim JS; Kim H; Choi IK; Yun CO; Seong J
J Radiat Res; 2012; 53(2):202-10. PubMed ID: 22510592
[TBL] [Abstract][Full Text] [Related]
40. Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro.
Shi M; Wang FS; Wu ZZ
World J Gastroenterol; 2003 Jan; 9(1):73-8. PubMed ID: 12508355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
